Cholesterol Monitors Market Insights, Outlook, Development and Trends 2022-2032

In 2022, it is anticipated that the Cholesterol Monitors Market is valued US$ 2,514.6 million. The cholesterol monitors market is expected to expand at a 7.4% CAGR from 2022 to 2032 and is likely generate US$ 4,502.4 million.

Rising rates of obesity and an aging population in developed nations like the U.S., Germany, and France have increased the cases of patients with high levels of bad cholesterol, necessitating a daily rise in the need for cholesterol monitoring kits worldwide.

The global market for cholesterol monitors is likely to expand due to the rising popularity of non-invasive technologies for cholesterol monitoring.

What are the Factors Propelling the Global Cholesterol Monitors Market?

The increasing prevalence of cardiovascular disorders, coupled with a growing emphasis on early diagnosis and miniaturization of cholesterol monitors, is expected to drive the growth of the global cholesterol monitor market. The preference for self-monitoring to enhance quality of life and lead a healthy lifestyle is another factor driving the expansion of the global market for cholesterol monitors.

Additionally, the market is likely to expand due to the increased focus on reducing the burden of cardiovascular diseases (CVDs) around the world, as well as initiatives for preventive healthcare practices like screening and health check-up programs.

The development of the global cholesterol monitor market is also aided by governmental changes that provide state-of-the-art healthcare facilities and awareness campaigns that are likely to raise the standard of testing.

Why is North America Emerging as an Opportunistic Cholesterol Monitors Market?

North America dominates the global cholesterol monitors market, accounting for nearly 35% in 2022. This market growth is primarily due to the rise in the incidence of CVDs, coupled with the rapidly aging population, high preference for self-monitoring devices, and increased awareness related to prevention and early diagnosis of the diseases in the region.

According to the Centers for Disease Control and Prevention, nearly 1 in 2 Americans have high cholesterol i.e., nearly 38% of American adults have high cholesterol (total blood cholesterol ≥ 200 mg/dL).1 Too much cholesterol puts you at risk for heart disease and stroke, two leading causes of death in the United States.

Owing to the increased risk of high cholesterol and its asymptomatic nature, the need for cholesterol monitors is burgeoning incessantly in the region. Additionally, the prevalence of heart diseases and obesity in the region is a major concern.

The United Health Foundation’s annual report revealed that the obesity rate increased from 31.5% in 2021 to 30.4% in 2020 in the United States. This, in turn, the mounting preference for preventive healthcare is also anticipated to drive regional growth. Rising awareness and initiatives from the government and several healthcare organizations are expected to propel market growth.

Key Players

  • Roche Diagnostics
  • PTS Diagnostics
  • Omron Healthcare, Inc.
  • ACON Laboratories, Inc.
  • AccuTech
  • LLC
  • Alere Inc.
  • Siemens
  • Medline Industries, Inc.
  • Abaxis, Inc.
  • ManthaMed
  • Fisher Scientific

Segments Covered

  • Product Type
  • End User

Key Segments Covered in the Cholesterol Monitors Industry Survey

By Product Type:

  • Single-sided COD Chip-On-Flex
  • Other Chip-On-Flex Types

By End Users:

  • Military
  • Medical
  • Aerospace
  • Electronics
  • Other Verticals

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Japan
  • Middle East and Africa

Read More @ https://www.futuremarketinsights.com/reports/cholesterol-monitors-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more